Adenosine A3 Receptor Antagonists [antagonisté adenosinového receptoru A3]

topical
Terms

A3 adenosinové receptory - antagonisté
adenosinové receptory A3 - antagonisté

Persistent link   https://www.medvik.cz/link/D058918
Definition

Compounds that selectively bind to and block the activation of ADENOSINE A3 RECEPTORS.

DUI
D058918 MeSH Browser
CUI
M0545367
Previous indexing
Receptor, Adenosine A3/antagonists & inhibitors (2004-2010)
History note
2011
Public note
2011

Allowable subheadings

AD
administration & dosage
AE
adverse effects
AN
analysis
BL
blood
CF
cerebrospinal fluid
CS
chemical synthesis
CH
chemistry
CL
classification
EC
economics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism
PK
pharmacokinetics
PD
pharmacology
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use
TO
toxicity
UR
urine

D Chemicals and Drugs
D27 Chemical Actions and Uses 374
D27.505 Pharmacologic Actions 409
D27.505.519 Molecular Mechanisms of Pharmacological Action 89
D27.505.519.625 Neurotransmitter Agents 517
D27.505.519.625.725 Purinergic Agents 2
D27.505.519.625.725.400 Purinergic Antagonists 1
D27.505.519.625.725.400.100 Purinergic P1 Receptor Antagonists 9
D27.505.519.625.725.400.100.100 Adenosine A1 Receptor Antagonists 4
D27.505.519.625.725.400.100.200 Adenosine A2 Receptor Antagonists 3
D27.505.519.625.725.400.100.300 Adenosine A3 Receptor Antagonists
D27.505.696 Physiological Effects of Drugs 52
D27.505.696.577 Neurotransmitter Agents 517
D27.505.696.577.725 Purinergic Agents 2
D27.505.696.577.725.400 Purinergic Antagonists 1
D27.505.696.577.725.400.100 Purinergic P1 Receptor Antagonists 9
D27.505.696.577.725.400.100.100 Adenosine A1 Receptor Antagonists 4
D27.505.696.577.725.400.100.200 Adenosine A2 Receptor Antagonists 3
D27.505.696.577.725.400.100.300 Adenosine A3 Receptor Antagonists

Back Add